Showing results (11-20 of 300) with videos related to
Sort By:
Pageof 30
Journal of Pharmaceutical Sciences|April 1, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids II: determination of an antiarrhythmic drug, tocainide, as its dansyl derivative using a fluorescence detectorP J Meffin, S R Harapat, D C HarrisonThe American Journal of Cardiology|October 31, 1975
Pharmacologic therapy of ventricular arrhythmiasR A Winkle, S A Glantz, D C HarrisonClinical Pharmacology and Therapeutics|April 1, 1982
Metabolite cumulation during long-term oral encainide administrationR E Kates, D C Harrison, R A WinkleAmerican Heart Journal|December 1, 1980
Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide successR A Winkle, J W Mason, D C HarrisonJournal of Chromatography|August 1, 1977
High-pressure liquid chromatographic analysis of drugs in biological fluids. V. Analysis of acebutolol and its major metaboliteP J Meffin, S R Harapat, Y G Yee, et al.The American Journal of Cardiology|April 1, 1983
Possible contribution of encainide metabolites to the long-term antiarrhythmic efficacy of encainideR A Winkle, F Peters, R E Kates, et al.American Heart Journal|August 1, 1982
Acute hemodynamic effects of intravenous encainide in patients with heart diseaseC R Tucker, R A Winkle, F A Peters, et al.Annals of Internal Medicine|July 1, 1976
Treatment of recurrent symptomatic ventricular tachycardiaR A Winkle, E L Alderman, J W Fitzgerald, et al.Circulation|July 1, 1977
Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery diseaseW B Ricks, R A Winkle, N E Shumway, et al.Circulation|August 1, 1981
Clinical pharmacology and antiarrhythmic efficacy of encainide in patients with chronic ventricular arrhythmiasR A Winkle, F Peters, R E Kates, et al.Pageof 30